Article
Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study
12 Feb 2021
Abstract excerpt
Objective: Levels of chitotriosidase (CHIT1) are increased in the cerebrospinal fluid (CSF) of amyotrophic lateral sclerosis (ALS) patients reflecting microglial activation. Here, we determine the diagnostic and prognostic potential of CHIT1 for early symptomatic ALS. Methods: Overall, 275 patients from 8 European neurological centers were examined. We included ALS with <6 and >6 months from symptom onset, other...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
